Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Oncogene|September 1, 2009
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpointsB Gruhne, R Sompallae, M G Masucci
Frontiers in Oncology|June 7, 2023
Ramakrishna R Sompallae, Bilge Dundar, Natalya V Guseva, et al.
American Journal of Clinical Pathology|February 25, 2022
Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With PrognosisAlexandra L Isaacson, Ramakrishna R Sompallae, Natalya V Guseva, et al.
Pathology, Research and Practice|April 17, 2024
Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtypeBilge Dundar, Mouaz Alsawas, Amr Masaadeh, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2021
Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular DystrophyAaron A Stence, Jon G Thomason, Jonathan A Pruessner, et al.
Leukemia|December 10, 2015
FOXM1 is a therapeutic target for high-risk multiple myelomaC Gu, Y Yang, R Sompallae, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 19, 2019
Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseasesM Adela Mansilla, Ramakrishna R Sompallae, Carla J Nishimura, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 20, 2016
Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing StrategyC P Thomas, M A Mansilla, R Sompallae, et al.
Blood Cancer Journal|November 5, 2016
Transgenic mouse model of IgM<sup>+</sup> lymphoproliferative disease mimicking Waldenström macroglobulinemiaV S Tompkins, R Sompallae, T R Rosean, et al.
Blood Cancer Journal|December 3, 2013
(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomibK Duncan, T R Rosean, V S Tompkins, et al.
Pageof 2